Hans D Ochs Selected Research

Immunoglobulin A (IgA)

3/2005	Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.
10/2004	The hyper IgM syndrome--an evolving story.
11/2003	Inducible CO-stimulator molecule, a candidate gene for defective isotype switching, is normal in patients with hyper-IgM syndrome of unknown molecular diagnosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans D Ochs Research Topics

Disease

27	Infections 01/2022 - 01/2002
22	Primary Immunodeficiency Diseases 01/2022 - 01/2002
17	Wiskott-Aldrich Syndrome 01/2022 - 12/2003
9	Type 1 Hyper-IgM Immunodeficiency Syndrome 01/2019 - 04/2002
9	Thrombocytopenia 1 01/2018 - 10/2003
8	Bruton type agammaglobulinemia 01/2022 - 04/2002
7	X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation 06/2020 - 08/2005
6	Neutropenia 01/2022 - 01/2008
6	Job Syndrome (Hyper-IgE Syndrome) 01/2019 - 07/2008
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2008
5	Thrombocytopenia (Thrombopenia) 06/2020 - 03/2002
5	Common Variable Immunodeficiency 01/2019 - 08/2008
5	Hemophilia A (Haemophilia) 11/2009 - 07/2004
4	Agammaglobulinemia (Hypogammaglobulinemia) 01/2022 - 07/2006
4	Neoplasms (Cancer) 01/2022 - 04/2003
4	Inflammation (Inflammations) 01/2022 - 10/2016
4	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2020 - 05/2002
4	Atopic Dermatitis (Atopic Eczema) 01/2019 - 11/2006
4	Reinfection 01/2016 - 11/2003
3	COVID-19 01/2022 - 01/2021
3	Measles 01/2022 - 12/2011
3	Bacterial Infections (Bacterial Infection) 06/2018 - 02/2010
3	Communicable Diseases (Infectious Diseases) 04/2014 - 12/2009
3	Pneumonia (Pneumonitis) 04/2012 - 01/2002
3	Tetanus 12/2011 - 11/2003
3	Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome) 09/2010 - 04/2002
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 12/2009 - 04/2003
2	Chronic Granulomatous Disease 01/2022 - 01/2020
2	Virus Diseases (Viral Diseases) 01/2022 - 02/2011
2	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 06/2020 - 12/2005
2	Food Hypersensitivity (Food Allergy) 06/2020 - 05/2007
2	Eczema 06/2020 - 09/2010
2	Leukemia 01/2020 - 09/2015
2	Cicatrix (Scar) 01/2019 - 04/2005
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2019 - 08/2008
2	Rubella (German Measles) 01/2019 - 12/2011
2	Eosinophilia 05/2018 - 05/2007
2	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2017 - 04/2014
2	Sepsis (Septicemia) 01/2015 - 07/2006
2	Hepatitis 12/2011 - 07/2006
2	Disease Susceptibility (Diathesis) 09/2010 - 09/2009
2	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2008 - 11/2003
1	Cytokine Release Syndrome 01/2022
1	Multiple Myeloma 01/2022
1	Hemorrhage 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021
1	Zika Virus Infection 01/2021

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2002
14	Immunoglobulin G (IgG)IBA 01/2022 - 03/2003
13	CD40 Ligand (CD40L)IBA 01/2019 - 04/2002
12	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 01/2002
11	Intravenous Immunoglobulins (IVIG)FDA Link 10/2018 - 01/2002
9	AntibodiesIBA 01/2022 - 04/2002
7	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 04/2002
7	Immunoglobulin M (IgM)IBA 01/2019 - 03/2003
6	Wiskott-Aldrich Syndrome ProteinIBA 01/2018 - 01/2004
5	Immunoglobulin E (IgE)IBA 01/2019 - 11/2006
5	DNA (Deoxyribonucleic Acid)IBA 09/2010 - 04/2003
5	Factor VIII (Coagulation Factor VIII)IBA 11/2009 - 07/2004
4	VaccinesIBA 01/2019 - 01/2002
4	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 02/2012 - 07/2008
3	AutoantibodiesIBA 01/2022 - 12/2018
3	Cytidine DeaminaseIBA 01/2019 - 11/2003
3	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 06/2018 - 11/2003
3	Immunoglobulin A (IgA)IBA 03/2005 - 11/2003
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022 - 12/2018
2	CytokinesIBA 01/2022 - 11/2006
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 06/2020
2	Peptides (Polypeptides)IBA 01/2020 - 11/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2016
2	Adenosine DeaminaseIBA 01/2019 - 02/2009
2	AntigensIBA 12/2011 - 10/2004
2	LigandsIBA 02/2009 - 09/2008
2	I-kappa B KinaseIBA 03/2005 - 11/2003
2	Uracil-DNA GlycosidaseIBA 03/2005 - 10/2003
2	NF-kappa B (NF-kB)IBA 10/2004 - 11/2003
1	Blood Proteins (Serum Proteins)IBA 01/2022
1	Immunologic Factors (Immunomodulators)IBA 01/2022
1	B-Cell Maturation AntigenIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	EpitopesIBA 01/2022
1	ChemokinesIBA 01/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022
1	NADP (NADPH)IBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	Virus ReceptorsIBA 01/2021

Therapy/Procedure

21	Therapeutics 01/2022 - 01/2002
6	Hematopoietic Stem Cell Transplantation 01/2022 - 07/2005
6	Cell Transplantation 01/2020 - 11/2010
3	Transplantation 04/2017 - 12/2009
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2016 - 04/2003
2	Splenectomy 01/2015 - 04/2010
1	Drug Therapy (Chemotherapy) 01/2022